|1.||Ghelardini, Carla: 3 articles (09/2015 - 03/2008)|
|2.||Farina, Carlo: 3 articles (09/2015 - 03/2008)|
|3.||Di Cesare Mannelli, Lorenzo: 2 articles (09/2015 - 06/2014)|
|4.||Maresca, Mario: 1 article (09/2015)|
|5.||Scherz, Michael W: 1 article (09/2015)|
|6.||Fariello, Ruggero G: 1 article (06/2014)|
|7.||Bonanno, Giambattista: 1 article (06/2014)|
|8.||Pittaluga, Anna: 1 article (06/2014)|
|9.||Milanese, Marco: 1 article (06/2014)|
|10.||Misiano, Paola: 1 article (06/2014)|
|1.||Neuralgia (Stump Neuralgia)
06/01/2014 - "Dimiracetam appears to be a promising and safe treatment for neuropathic pain conditions for which there are very limited therapeutic options. "
03/15/2008 - "Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain."
06/01/2014 - "Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain."
09/01/2015 - "A model of neuropathic pain induced by sorafenib in the rat: Effect of dimiracetam."
06/01/2014 - "Dimiracetam, a bicyclic 2-pyrrolidinone derivative originally developed as cognition enhancer, is a member of the nootropic family for which anecdotal efficacy in models of neuropathic pain has been reported. "
06/01/2014 - "Chronic dimiracetam dosing in the MIA and ART- induced models completely reverted hyperalgesia back to the level of healthy controls. "
06/01/2014 - "Acutely, dimiracetam was very effective in models of antiretroviral drug induced painful neuropathy, oxaliplatin-induced hyperalgesia and in the MIA-osteoarthritis. "
|2.||sorafenib (BAY 43-9006)